Adamas Pharmaceuticals Inc. (NASDAQ: ADMS) started the day on February 17, 2021, with a price decrease of -2.64% at $5.89. During the day, the stock rose to $5.96 and sunk to $5.43 before settling in for the price of $6.05 at the close. Taking a more long-term approach, ADMS posted a 52-week range of $1.90-$9.15.
It was noted that the giant of the Healthcare sector posted annual sales growth of -0.40% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -52.90%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 22.00%. This publicly-traded company’s shares outstanding now amounts to $28.38 million, simultaneously with a float of $27.75 million. The organization now has a market capitalization sitting at $175.11 million. At the time of writing, stock’s 50-day Moving Average stood at $5.10, while the 200-day Moving Average is $4.01.
It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 136 workers. It has generated 401,743 per worker during the last fiscal year. Meanwhile, its income per employee was -773,426. The stock had 7.65 Receivables turnover and 0.28 Total Asset turnover. For the Profitability, stocks gross margin was +95.48, operating margin was -168.81 and Pretax Margin of -192.52.
Adamas Pharmaceuticals Inc. (ADMS) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Drug Manufacturers – Specialty & Generic Industry. Adamas Pharmaceuticals Inc.’s current insider ownership accounts for 0.70%, in contrast to 63.00% institutional ownership. According to the most recent insider trade that took place on Feb 01, this organization’s Chief Financial Officer sold 3,821 shares at the rate of 6.36, making the entire transaction reach 24,302 in total value, affecting insider ownership by 72,439. Preceding that transaction, on Feb 01, Company’s Chief Commercial Officer sold 4,514 for 6.39, making the whole transaction’s value amount to 28,844. This particular insider is now the holder of 95,486 in total.
Adamas Pharmaceuticals Inc. (ADMS) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 9/29/2020, the organization reported -$0.42 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at -$0.48) by $0.06. This company achieved a net margin of -192.52 while generating a return on equity of -236.39. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.45 per share during the current fiscal year.
Adamas Pharmaceuticals Inc.’s EPS increase for this current 12-month fiscal period is 22.00% and is forecasted to reach -1.22 in the upcoming year.
Adamas Pharmaceuticals Inc. (NASDAQ: ADMS) Trading Performance Indicators
Let’s observe the current performance indicators for Adamas Pharmaceuticals Inc. (ADMS). It’s Quick Ratio in the last reported quarter now stands at 3.70. The Stock has managed to achieve an average true range (ATR) of 0.60. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.51.
In the same vein, ADMS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.22, a figure that is expected to reach -0.50 in the next quarter, and analysts are predicting that it will be -1.22 at the market close of one year from today.
Technical Analysis of Adamas Pharmaceuticals Inc. (ADMS)
If we take a close look at the recent performances of Adamas Pharmaceuticals Inc. (NASDAQ: ADMS), its last 5-days Average volume was 0.71 million that shows plunge from its year to date volume of 0.89 million. During the previous 9 days, stock’s Stochastic %D was recorded 45.71% While, its Average True Range was 0.62.
Raw Stochastic average of Adamas Pharmaceuticals Inc. (ADMS) in the period of the previous 100 days is set at 47.33%, which indicates a major rise in contrast to 18.50% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 119.85% that was higher than 75.81% volatility it exhibited in the past 100-days period.